Twin City Private Wealth LLC Invests $1.15 Million in Healthpeak Properties, Inc. $DOC

Twin City Private Wealth LLC acquired a new stake in Healthpeak Properties, Inc. (NYSE:DOC) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 59,945 shares of the real estate investment trust’s stock, valued at approximately $1,148,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Norges Bank purchased a new stake in Healthpeak Properties during the second quarter valued at about $140,558,000. Nordea Investment Management AB lifted its stake in shares of Healthpeak Properties by 7,444.0% in the 2nd quarter. Nordea Investment Management AB now owns 3,923,205 shares of the real estate investment trust’s stock valued at $67,871,000 after acquiring an additional 3,871,201 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Healthpeak Properties by 21.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 20,024,030 shares of the real estate investment trust’s stock valued at $350,621,000 after acquiring an additional 3,540,367 shares during the period. Prudential Financial Inc. boosted its holdings in Healthpeak Properties by 153.4% during the 2nd quarter. Prudential Financial Inc. now owns 2,861,443 shares of the real estate investment trust’s stock valued at $50,104,000 after acquiring an additional 1,732,187 shares during the period. Finally, Equity Investment Corp bought a new position in Healthpeak Properties during the 2nd quarter worth approximately $30,154,000. Institutional investors own 93.57% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on DOC shares. Weiss Ratings upgraded Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday. Robert W. Baird lowered their price target on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a report on Wednesday, November 12th. Jefferies Financial Group cut shares of Healthpeak Properties from a “buy” rating to a “hold” rating and dropped their price target for the company from $21.00 to $17.00 in a research report on Monday, December 15th. The Goldman Sachs Group assumed coverage on shares of Healthpeak Properties in a research report on Friday, January 9th. They issued a “neutral” rating and a $17.00 price objective on the stock. Finally, Evercore ISI dropped their target price on shares of Healthpeak Properties from $22.00 to $21.00 and set an “outperform” rating for the company in a report on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $19.67.

Healthpeak Properties Price Performance

Shares of NYSE DOC opened at $17.22 on Friday. Healthpeak Properties, Inc. has a 1 year low of $15.71 and a 1 year high of $21.28. The stock has a market capitalization of $11.97 billion, a P/E ratio of -344.33, a P/E/G ratio of 4.32 and a beta of 1.12. The company’s 50-day moving average is $17.00 and its 200 day moving average is $17.66. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.22 and a quick ratio of 1.22.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a dividend of $0.1017 per share. The ex-dividend date is Tuesday, March 17th. This represents a c) annualized dividend and a dividend yield of 7.1%. Healthpeak Properties’s payout ratio is currently -2,440.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.